Ivermectin + Pyrantel Pamoate

Verify with FDA CVM →

2,818 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
2,818
Total Reports
68
Deaths Reported
240.0%
Death Rate

Active Ingredients

IvermectinIvermectin + Pyrantel PamoatePyrantel Pamoate

Administration Routes

OralUnknownTopicalOphthalmicIntrauterine

Species Affected

Dog 2,759
Unknown 56
Human 3

Most Affected Breeds

Retriever - Labrador 374
Shepherd Dog - German 161
Crossbred Canine/dog 126
Chihuahua 119
Terrier - Yorkshire 99
Pit Bull 95
Dog (unknown) 87
Retriever - Golden 84
Shih Tzu 83
Boxer (German Boxer) 73

Most Reported Reactions

Lack of efficacy (endoparasite) - heartworm 789
Emesis 577
Vomiting 390
Lethargy (see also Central nervous system depression in 'Neurological') 224
Lack of efficacy (ectoparasite) - flea 155
Diarrhoea 136
Seizure NOS 93
INEFFECTIVE, HEARTWORM LARVAE 87
Other abnormal test result NOS 74
Not eating 70
Lack of efficacy - NOS 70
Behavioural disorder NOS 65

Outcome Breakdown

Outcome Unknown
1,281 (46.4%)
Recovered/Normal
1,090 (39.4%)
Ongoing
191 (6.9%)
Recovered with Sequela
133 (4.8%)
Died
35 (1.3%)
Euthanized
33 (1.2%)

Data Summary

Metric Value
Total adverse event reports 2,818
Reports involving death 68
Case-fatality rate (reported events) 240.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 3

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin + Pyrantel Pamoate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 2,818 adverse event reports referencing Ivermectin + Pyrantel Pamoate, including 68 reports in which the animal died — a 240.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredients on file: Ivermectin, Ivermectin + Pyrantel Pamoate, Pyrantel Pamoate. Reported administration routes include Oral, Unknown, Topical, Ophthalmic. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin + Pyrantel Pamoate reports are Dog (2,759 reports), Unknown (56 reports), Human (3 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (374), Shepherd Dog - German (161), Crossbred Canine/dog (126) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin + Pyrantel Pamoate are Lack of efficacy (endoparasite) - heartworm (789), Emesis (577), Vomiting (390), Lethargy (see also Central nervous system depression in 'Neurological') (224). Of the 2,763 reports with a coded outcome, Outcome Unknown is the leading category at 46.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin + Pyrantel Pamoate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial